Heart Failure Virtual Ward Research Study
Key facts
- Where
- Ballinasloe, ÍrországSee the site
Where in Írország
- Portiuncula University HospitalBallinasloe, ÍrországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National University of Ireland, Galway, Ireland
- Trial code
- NCT06620653
- Record updated
- 2026. április 15.
- Original description
The main aim will be to evaluate whether a follow-up with virtual wards reduces HF hospitalisation at three months follow-up. Hospital admission will be defined as any hospital admission, or an emergency room stay of more than 24 h requiring IV diuretics.Read full original descriptionShow less
The main aim will be to evaluate whether a follow-up with virtual wards reduces HF hospitalisation at three months follow-up. Hospital admission will be defined as any hospital admission, or an emergency room stay of more than 24 h requiring IV diuretics.
The secondary objectives will be to evaluate whether this intervention reduces all-cause mortality, all-cause hospitalisation at three months, is cost-effectiveness, is associated with a higher percentage of prescription and dose of prognostic medication and improves the quality of life. To assess the potential long-term effects of the virtual wards follow-up, we will evaluate whether this intervention reduces all-cause mortality and HF hospitalisation at 6- and 12-months by a telephone call/virtual outpatients' appointment.
The study outcomes will be ascertained at each visit. Given the study design, it is impossible to assess the endpoints in a blinded manner. Clinical events during the study will be adjudicated by an operational committee whose members will be unaware of the group assignment.
Inclusion: Adult patients (≥ 18 years) with a recent hospitalisation; Known ejection fraction and NYHA Class; Known or de novo Heart Failure; Patient or carer able to speak and understand English/Irish; Willing to participate in the study; Within catchment area of the Saolta group.
Exclusion: Patients who, at the investigator's discretion, are considered unable to participate in the study, mainly due to a previous history of non- compliance with medication and follow-up appointments, language barrier, or moderate or severe cognitive impairment without the support of a family member/caregiver; Patients with asymptomatic (NYHA class I) left ventricular dysfunction, usually in the setting of an acute myocardial infarction; Patients who decline to participate in the study; Patient in palliative care or with a life expectancy of less than one year; Patients referred to skilled nursing facilities or nursing homes at hospital discharge; Patients with planned intervention on the mitral or aortic valve during admission or scheduled early after discharge; Planned haemodialysis; Patients included in other randomized controlled trials; The lack of information technology (IT) literacy will not be an exclusion criterion.